Polycythemia vera
97 results
1 - 97
Polycythemia Vera- BASICS
- DESCRIPTION
- EPIDEMIOLOGY
- ETIOLOGY AND PATHOPHYSIOLOGY
- RISK FACTORS
- GENERAL PREVENTION
- COMMONLY ASSOCIATED CONDITIONS
- DIAGNOSIS
- TREATMENT
- GENERAL MEASURES
- MEDICATION
- ISSUES FOR REFERRAL
- COMPLEMENTARY & ALTERNATIVE MEDICINE
- ADMISSION, INPATIENT, AND NURSING CONSIDERATIONS
- ONGOING CARE
- Authors
- REFERENCES
- ADDITIONAL READING
- CODES
- CLINICAL PEARLS
Polycythemia vera- Polycythemia
ropeginterferon alfa-2b- Myeloproliferative Neoplasms
- Erythromelalgia
Red blood cell count- mercaptopurine
- procarbazine
- Chronic myelogenous leukemia
- Erythropoietin (EPO)
- ruxolitinib (systemic)
- Retinal vein occlusion
- Thrombocytosis
- Erythrocytosis
- Amaurosis fugax
- Acute leukemia
- Qualitative platelet disorders
- Budd-Chiari syndrome (hepatic vein obstruction)
- THROMBOCYTOSIS: DIAGNOSTIC EVALUATION OF SUSTAINED THROMBOCYTOSIS
- Epistaxis
- JAK2 (V617F) mutation
- Pruritus (itching)
- Mean corpuscular volume
- Leukemia, Chronic Myelogenous
- Erythromelalgia
- Hypercoagulable state
- Lactate dehydrogenase
- Acute visual loss
- Vitamin B12
- Hematocrit
- Splenomegaly
- Pulmonary hypertension
- Uric acid
- Platelet count
- Tardive Dyskinesia
- Epistaxis
Pruritus- Budd-Chiari Syndrome
- Leukocytosis
- cyanocobalamin
- Partial thromboplastin time
- Calreticulin (CALR) mutation analysis
- Thrombophilia and Hypercoagulable States